報價延遲最少15分鐘:2025/08/25 09:24 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.97/-0.16
|
|
企業價值
176.94M
|
| 資產負債 |
|
每股賬面淨值
-0.48
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
64.25M
|
|
每股收益
1.51
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/25 09:24 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US. |
